Insmed Incorporated (LON:0JAV)
206.82
+1.96 (0.96%)
At close: Nov 28, 2025
Insmed Revenue
Insmed had revenue of $142.34M USD in the quarter ending September 30, 2025, with 52.36% growth. This brings the company's revenue in the last twelve months to $447.02M, up 30.34% year-over-year. In the year 2024, Insmed had annual revenue of $363.71M with 19.17% growth.
Revenue (ttm)
$447.02M
Revenue Growth
+30.34%
P/S Ratio
100.66
Revenue / Employee
$351.71K
Employees
1,271
Market Cap
33.47B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 363.71M | 58.50M | 19.17% |
| Dec 31, 2023 | 305.21M | 59.85M | 24.39% |
| Dec 31, 2022 | 245.36M | 56.90M | 30.19% |
| Dec 31, 2021 | 188.46M | 24.05M | 14.63% |
| Dec 31, 2020 | 164.41M | 27.95M | 20.48% |
| Dec 31, 2019 | 136.47M | 126.63M | 1,287.56% |
| Dec 31, 2018 | 9.84M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | 11.50M | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | 4.42M | -2.50M | -36.18% |
| Dec 31, 2010 | 6.92M | -3.45M | -33.28% |
| Dec 31, 2009 | 10.37M | -1.33M | -11.33% |
| Dec 31, 2008 | 11.70M | 4.12M | 54.32% |
| Dec 31, 2007 | 7.58M | 6.56M | 639.61% |
| Dec 31, 2006 | 1.03M | 894.00K | 682.44% |
| Dec 31, 2005 | 131.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Insmed News
- 5 days ago - This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks He’s Buying Now. - 24/7 Wall street
- 9 days ago - These 15 stocks are still showing momentum — and a market-beating edge - Market Watch
- 9 days ago - INSM: TD Cowen Raises Price Target, Maintains Buy Rating | INSM Stock News - GuruFocus
- 10 days ago - Insmed Stock Rise on EU Nod for Lung Disease Drug, Brinsupri - Nasdaq
- 10 days ago - Insmed's BRINSUPRI Wins EU Approval, Expanding Global Reach After U.S. Nod - Nasdaq
- 11 days ago - Insider Sell: Leo Lee Sells 75,000 Shares of Insmed Inc (INSM) - GuruFocus
- 11 days ago - Peering Into Insmed Inc's Recent Short Interest - Benzinga
- 11 days ago - Insmed (INSM) Gains EU Approval for First NCFB Treatment - GuruFocus